Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B Drug Pricing Program

PURPOSE: Safety-net health systems, which serve a disproportionate share of patients at high risk for hepatitis C virus (HCV) infection, may use revenue generated by the federal drug discount pricing program, known as 340B, to support multidisciplinary care. Budgetary impacts of repealing the drug-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Eric A., Linas, Benjamin P., Truong, Ve, Burgess, James F., Lasser, Karen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417774/
https://www.ncbi.nlm.nih.gov/pubmed/30870475
http://dx.doi.org/10.1371/journal.pone.0213745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417774/
https://www.ncbi.nlm.nih.gov/pubmed/30870475
http://dx.doi.org/10.1371/journal.pone.0213745

Ejemplares similares